The Intellectual Property Laws Amendment Act 2015 (Amendment Act) amended the Patents Act 1990, Trade Marks Act 1995, Designs Act 2003, and the Plant Breeder's Rights Act 1994 to:
implement the Protocol amending the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property (TRIPS Protocol), enabling Australian medicine producers to manufacture and export patented pharmaceuticals to countries experiencing health crises,...More
In November 2011, the Government responded to three reports on gene patents and patentable subject matter:
Senate Community Affairs References Committee Gene Patents Report
Advisory Council on Intellectual Property report Patentable Subject Matter
Australian Law Reform Commission report Genes and Ingenuity: Gene Patenting and Human Health.
The Government accepted recommendations to amend the Patents Act 1990 to introduce:
an objects clause to...More
On 15 October 2012, the Hon Mark Dreyfus QC MP, announced a review of pharmaceutical patents.
The review is to examine whether Australia’s patent system is effective in securing timely access to competitively priced pharmaceuticals and in supporting innovation and employment in the industry. An important part of the review is to examine the Australian provisions for extending the terms of eligible pharmaceutical patents.
The Review Panel issued a background paper , with...More
The IP Laws Amendment (Raising the Bar) Act 2012 is Australia's biggest intellectual property (IP) system overhaul in twenty years. The legislative reforms aimed to strike a balance between public and private interests and provide a more robust framework to support and encourage innovation.
The Raising the Bar Act addressed the following six key areas:
Raising the quality of granted patents: Australia patentability standards are now more closely aligned to...More